Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam

Fatty acid esters are long-chain esters, produced from the reaction of fatty acids and alcohols. They possess potential applications in cosmetic and pharmaceutical formulations due to their excellent wetting behaviour at interfaces and a non-greasy feeling when applied on the skin surfaces. This pre...

Full description

Bibliographic Details
Published in:AAPS PharmSciTech
Main Author: Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
Format: Article
Language:English
Published: 2013
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878538977&doi=10.1208%2fs12249-013-9929-1&partnerID=40&md5=2a801cc3785db6de42333e16a2fef1ab
id 2-s2.0-84878538977
spelling 2-s2.0-84878538977
Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
2013
AAPS PharmSciTech
14
1
10.1208/s12249-013-9929-1
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878538977&doi=10.1208%2fs12249-013-9929-1&partnerID=40&md5=2a801cc3785db6de42333e16a2fef1ab
Fatty acid esters are long-chain esters, produced from the reaction of fatty acids and alcohols. They possess potential applications in cosmetic and pharmaceutical formulations due to their excellent wetting behaviour at interfaces and a non-greasy feeling when applied on the skin surfaces. This preliminary work was carried out to construct pseudo-ternary phase diagrams for oleyl laurate, oleyl stearate and oleyl oleate with surfactants and piroxicam. Then, the preparation and optimization study via 'One-At-A-Time Approach' were carried out to determine the optimum amount of oil, surfactants and stabilizer using low-energy emulsification method. The results revealed that multi-phase region dominated the three pseudo-ternary phase diagrams. A composition was chosen from each multi-phase region for preparing the nanoemulsions systems containing piroxicam by incorporating a hydrocolloid stabilizer. The results showed that the optimum amount (w/w) of oil for oleyl laurate nanoemulsions was 30 and 20 g (w/w) for oleyl stearate nanoemulsions and oleyl oleate nanoemulsions. For each nanoemulsions system, the amount of mixed surfactants and stabilizer needed for the emulsification to take place was found to be 10 and 0.5 g (w/w), respectively. The emulsification process via high-energy emulsification method successfully produced nano-sized range particles. The nanoemulsions systems passed the centrifugation test and freeze-thaw cycle with no phase failures, and stable for 3 months at various storage temperatures (3 C, 25 C and 45 C). The results proved that the prepared nanoemulsions system cannot be formed spontaneously, and thus, energy input was required to produce nano-sized range particles. © 2013 American Association of Pharmaceutical Scientists.

15309932
English
Article
All Open Access; Green Open Access
author Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
spellingShingle Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
author_facet Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
author_sort Mat Hadzir N.; Basri M.; Abdul Rahman M.B.; Salleh A.B.; Raja Abdul Rahman R.N.Z.; Basri H.
title Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
title_short Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
title_full Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
title_fullStr Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
title_full_unstemmed Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
title_sort Phase behaviour and formation of fatty acid esters nanoemulsions containing piroxicam
publishDate 2013
container_title AAPS PharmSciTech
container_volume 14
container_issue 1
doi_str_mv 10.1208/s12249-013-9929-1
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878538977&doi=10.1208%2fs12249-013-9929-1&partnerID=40&md5=2a801cc3785db6de42333e16a2fef1ab
description Fatty acid esters are long-chain esters, produced from the reaction of fatty acids and alcohols. They possess potential applications in cosmetic and pharmaceutical formulations due to their excellent wetting behaviour at interfaces and a non-greasy feeling when applied on the skin surfaces. This preliminary work was carried out to construct pseudo-ternary phase diagrams for oleyl laurate, oleyl stearate and oleyl oleate with surfactants and piroxicam. Then, the preparation and optimization study via 'One-At-A-Time Approach' were carried out to determine the optimum amount of oil, surfactants and stabilizer using low-energy emulsification method. The results revealed that multi-phase region dominated the three pseudo-ternary phase diagrams. A composition was chosen from each multi-phase region for preparing the nanoemulsions systems containing piroxicam by incorporating a hydrocolloid stabilizer. The results showed that the optimum amount (w/w) of oil for oleyl laurate nanoemulsions was 30 and 20 g (w/w) for oleyl stearate nanoemulsions and oleyl oleate nanoemulsions. For each nanoemulsions system, the amount of mixed surfactants and stabilizer needed for the emulsification to take place was found to be 10 and 0.5 g (w/w), respectively. The emulsification process via high-energy emulsification method successfully produced nano-sized range particles. The nanoemulsions systems passed the centrifugation test and freeze-thaw cycle with no phase failures, and stable for 3 months at various storage temperatures (3 C, 25 C and 45 C). The results proved that the prepared nanoemulsions system cannot be formed spontaneously, and thus, energy input was required to produce nano-sized range particles. © 2013 American Association of Pharmaceutical Scientists.
publisher
issn 15309932
language English
format Article
accesstype All Open Access; Green Open Access
record_format scopus
collection Scopus
_version_ 1809678161995104256